Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.

Leukemia & lymphoma - 1 Jun 2005

Imamura Takaaki, Yokosuka Osamu, Chiba Tetsuhiro, Kanda Tatso, Kojima Hiroshige, Fukai Kenichi, Imazeki Fumio, Nishimura Miki, Saito Yasushi, Saisho Hiromitsu

Abstract excerpt

We report the case of a 52-year-old woman with hepatitis B virus (HBV) reactivation during treatment for chronic graft vs. host disease (GVHD) after peripheral bone marrow transplantation (PBSCT) to treat chronic myelocytic leukemia. She was given cyclosporine and prednisolone orally to treat chr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to Bone Marrow Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Replication

Share to Graft vs Host Disease

Share to Hepatitis B

Share to Immunosuppressive Agents

Share to Lamivudine

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Source

Identifiers

PMID: 16019538
DOI: 10.1080/10428190500051091

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16019538-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.PMID 16019538Read ↗

Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.Semantic proximity Read ↗

Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.Semantic proximity Read ↗

Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.Semantic proximity Read ↗

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.Semantic proximity Read ↗

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.Semantic proximity Read ↗

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.Semantic proximity Read ↗

Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.Semantic proximity Read ↗

Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges.Semantic proximity Read ↗

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.Semantic proximity Read ↗

Hepatitis B immune globulin: the US experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.